APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Therapy for Osteoarthritis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Stem Cell Therapy for Osteoarthritis Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchStem Cell Therapy for Osteoarthritis Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Therapy for Osteoarthritis Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Stem Cell Therapy for Osteoarthritis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Therapy for Osteoarthritis Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Therapy for Osteoarthritis Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Stem Cell Therapy for Osteoarthritis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Stem Cell Therapy for Osteoarthritis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Stem Cell Therapy for Osteoarthritis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Stem Cell Therapy for Osteoarthritis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Stem Cell Therapy for Osteoarthritis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Stem Cell Therapy for Osteoarthritis include Xintela AB, UCI Health, Theracell Advanced Biotechnology, Stempeutics, Regeneus, Nature Cell, Medipost, Magellan and CellTex Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Stem Cell Therapy for Osteoarthritis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Stem Cell Therapy for Osteoarthritis, also provides the revenue of main regions and countries. Of the upcoming market potential for Stem Cell Therapy for Osteoarthritis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stem Cell Therapy for Osteoarthritis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Stem Cell Therapy for Osteoarthritis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Stem Cell Therapy for Osteoarthritis revenue, projected growth trends, production technology, application and end-user industry.

Stem Cell Therapy for Osteoarthritis Segment by Company

Xintela AB

UCI Health

Theracell Advanced Biotechnology

Stempeutics

Regeneus

Nature Cell

Medipost

Magellan

CellTex Therapeutics

Cells for Cells

AbelZeta Pharma

Stem Cell Therapy for Osteoarthritis Segment by Type

Fat Cell

Bone Marrow Cell

Others

Stem Cell Therapy for Osteoarthritis Segment by Application

Primary Osteoarthritis

Secondary Osteoarthritis

Stem Cell Therapy for Osteoarthritis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy for Osteoarthritis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy for Osteoarthritis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy for Osteoarthritis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Stem Cell Therapy for Osteoarthritis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Stem Cell Therapy for Osteoarthritis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapy for Osteoarthritis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fat Cell Major Player Table 3. Bone Marrow Cell Major Player Table 4. Others Major Player Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Primary Osteoarthritis Major Player Table 7. Secondary Osteoarthritis Major Player Table 8. Stem Cell Therapy for Osteoarthritis Industry Trends Table 9. Stem Cell Therapy for Osteoarthritis Industry Drivers Table 10. Stem Cell Therapy for Osteoarthritis Industry Opportunities and Challenges Table 11. Stem Cell Therapy for Osteoarthritis Industry Restraints Table 12. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2021-2026) Table 15. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2027-2032) Table 17. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2021-2026) Table 19. Global Stem Cell Therapy for Osteoarthritis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Stem Cell Therapy for Osteoarthritis Key Players Headquarters & Area Served Table 21. Global Stem Cell Therapy for Osteoarthritis Players, Product Type & Application Table 22. Global Stem Cell Therapy for Osteoarthritis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Stem Cell Therapy for Osteoarthritis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Stem Cell Therapy for Osteoarthritis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2021-2026) Table 29. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2027-2032) Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2021-2026) Table 34. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2027-2032) Table 35. Xintela AB Company Information Table 36. Xintela AB Business Overview Table 37. Xintela AB Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Xintela AB Stem Cell Therapy for Osteoarthritis Product Portfolio Table 39. Xintela AB Recent Development Table 40. UCI Health Company Information Table 41. UCI Health Business Overview Table 42. UCI Health Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. UCI Health Stem Cell Therapy for Osteoarthritis Product Portfolio Table 44. UCI Health Recent Development Table 45. Theracell Advanced Biotechnology Company Information Table 46. Theracell Advanced Biotechnology Business Overview Table 47. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product Portfolio Table 49. Theracell Advanced Biotechnology Recent Development Table 50. Stempeutics Company Information Table 51. Stempeutics Business Overview Table 52. Stempeutics Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Stempeutics Stem Cell Therapy for Osteoarthritis Product Portfolio Table 54. Stempeutics Recent Development Table 55. Regeneus Company Information Table 56. Regeneus Business Overview Table 57. Regeneus Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Regeneus Stem Cell Therapy for Osteoarthritis Product Portfolio Table 59. Regeneus Recent Development Table 60. Nature Cell Company Information Table 61. Nature Cell Business Overview Table 62. Nature Cell Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Nature Cell Stem Cell Therapy for Osteoarthritis Product Portfolio Table 64. Nature Cell Recent Development Table 65. Medipost Company Information Table 66. Medipost Business Overview Table 67. Medipost Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Medipost Stem Cell Therapy for Osteoarthritis Product Portfolio Table 69. Medipost Recent Development Table 70. Magellan Company Information Table 71. Magellan Business Overview Table 72. Magellan Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Magellan Stem Cell Therapy for Osteoarthritis Product Portfolio Table 74. Magellan Recent Development Table 75. CellTex Therapeutics Company Information Table 76. CellTex Therapeutics Business Overview Table 77. CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product Portfolio Table 79. CellTex Therapeutics Recent Development Table 80. Cells for Cells Company Information Table 81. Cells for Cells Business Overview Table 82. Cells for Cells Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Cells for Cells Stem Cell Therapy for Osteoarthritis Product Portfolio Table 84. Cells for Cells Recent Development Table 85. AbelZeta Pharma Company Information Table 86. AbelZeta Pharma Business Overview Table 87. AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product Portfolio Table 89. AbelZeta Pharma Recent Development Table 90. North America Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Stem Cell Therapy for Osteoarthritis Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Stem Cell Therapy for Osteoarthritis Revenue by Country (US$ Million) & (2027-2032) Table 104. China Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026) & (US$ Million) Table 105. China Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032) & (US$ Million) Table 106. China Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026) & (US$ Million) Table 107. China Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Stem Cell Therapy for Osteoarthritis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Stem Cell Therapy for Osteoarthritis Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Stem Cell Therapy for Osteoarthritis Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Stem Cell Therapy for Osteoarthritis Image Figure 2. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cell Therapy for Osteoarthritis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fat Cell Image Figure 5. Bone Marrow Cell Image Figure 6. Others Image Figure 7. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Stem Cell Therapy for Osteoarthritis Market Size Share 2021 VS 2025 VS 2032 Figure 9. Primary Osteoarthritis Image Figure 10. Secondary Osteoarthritis Image Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million) & (2021-2032) Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Stem Cell Therapy for Osteoarthritis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Stem Cell Therapy for Osteoarthritis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Stem Cell Therapy for Osteoarthritis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2021-2032) Figure 19. Global Stem Cell Therapy for Osteoarthritis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2021-2032) Figure 22. North America Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032) Figure 24. North America Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032) Figure 25. North America Stem Cell Therapy for Osteoarthritis Revenue Share by Country (2021-2032) Figure 26. United States Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032) Figure 31. Europe Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032) Figure 32. Europe Stem Cell Therapy for Osteoarthritis Revenue Share by Country (2021-2032) Figure 33. Germany Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032) Figure 43. China Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032) Figure 44. Asia Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032) Figure 46. Asia Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032) Figure 47. Asia Stem Cell Therapy for Osteoarthritis Revenue Share by Region (2021-2032) Figure 48. Japan Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032) Figure 56. SAMEA Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032) Figure 57. SAMEA Stem Cell Therapy for Osteoarthritis Revenue Share by Country (2021-2032) Figure 58. Brazil Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Stem Cell Therapy for Osteoarthritis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Fat Cell
  • Bone Marrow Cell
  • Others
Applications
  • Primary Osteoarthritis
  • Secondary Osteoarthritis
Companies covered
  • Xintela AB
  • UCI Health
  • Theracell Advanced Biotechnology
  • Stempeutics
  • Regeneus
  • Nature Cell
  • Medipost
  • Magellan
  • CellTex Therapeutics
  • Cells for Cells
  • AbelZeta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Stem Cell Therapy for Osteoarthritis Market by Type
  3. 1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fat Cell
  5. 1.2.3 Bone Marrow Cell
  6. 1.2.4 Others
  7. 1.3 Stem Cell Therapy for Osteoarthritis Market by Application
  8. 1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Primary Osteoarthritis
  10. 1.3.3 Secondary Osteoarthritis
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Stem Cell Therapy for Osteoarthritis Market Dynamics
  1. 2.1 Stem Cell Therapy for Osteoarthritis Industry Trends
  2. 2.2 Stem Cell Therapy for Osteoarthritis Industry Drivers
  3. 2.3 Stem Cell Therapy for Osteoarthritis Industry Opportunities and Challenges
  4. 2.4 Stem Cell Therapy for Osteoarthritis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2021-2032)
  2. 3.2 Global Stem Cell Therapy for Osteoarthritis Growth Trends by Region
  3. 3.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2021-2026)
  5. 3.2.3 Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Stem Cell Therapy for Osteoarthritis Revenue by Players
  2. 4.1.1 Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2021-2026)
  3. 4.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Stem Cell Therapy for Osteoarthritis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Stem Cell Therapy for Osteoarthritis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Stem Cell Therapy for Osteoarthritis Key Players Headquarters & Area Served
  7. 4.4 Global Stem Cell Therapy for Osteoarthritis Players, Product Type & Application
  8. 4.5 Global Stem Cell Therapy for Osteoarthritis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Stem Cell Therapy for Osteoarthritis Market CR5 and HHI
  11. 4.6.3 2025 Stem Cell Therapy for Osteoarthritis Tier 1, Tier 2, and Tier 3
5 Stem Cell Therapy for Osteoarthritis Market Size by Type
  1. 5.1 Global Stem Cell Therapy for Osteoarthritis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2032)
  3. 5.3 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2021-2032)
6 Stem Cell Therapy for Osteoarthritis Market Size by Application
  1. 6.1 Global Stem Cell Therapy for Osteoarthritis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2032)
  3. 6.3 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Xintela AB
  2. 7.1.1 Xintela AB Company Information
  3. 7.1.2 Xintela AB Business Overview
  4. 7.1.3 Xintela AB Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Xintela AB Stem Cell Therapy for Osteoarthritis Product Portfolio
  6. 7.1.5 Xintela AB Recent Developments
  7. 7.2 UCI Health
  8. 7.2.1 UCI Health Company Information
  9. 7.2.2 UCI Health Business Overview
  10. 7.2.3 UCI Health Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 UCI Health Stem Cell Therapy for Osteoarthritis Product Portfolio
  12. 7.2.5 UCI Health Recent Developments
  13. 7.3 Theracell Advanced Biotechnology
  14. 7.3.1 Theracell Advanced Biotechnology Company Information
  15. 7.3.2 Theracell Advanced Biotechnology Business Overview
  16. 7.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product Portfolio
  18. 7.3.5 Theracell Advanced Biotechnology Recent Developments
  19. 7.4 Stempeutics
  20. 7.4.1 Stempeutics Company Information
  21. 7.4.2 Stempeutics Business Overview
  22. 7.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Stempeutics Stem Cell Therapy for Osteoarthritis Product Portfolio
  24. 7.4.5 Stempeutics Recent Developments
  25. 7.5 Regeneus
  26. 7.5.1 Regeneus Company Information
  27. 7.5.2 Regeneus Business Overview
  28. 7.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Regeneus Stem Cell Therapy for Osteoarthritis Product Portfolio
  30. 7.5.5 Regeneus Recent Developments
  31. 7.6 Nature Cell
  32. 7.6.1 Nature Cell Company Information
  33. 7.6.2 Nature Cell Business Overview
  34. 7.6.3 Nature Cell Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Nature Cell Stem Cell Therapy for Osteoarthritis Product Portfolio
  36. 7.6.5 Nature Cell Recent Developments
  37. 7.7 Medipost
  38. 7.7.1 Medipost Company Information
  39. 7.7.2 Medipost Business Overview
  40. 7.7.3 Medipost Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medipost Stem Cell Therapy for Osteoarthritis Product Portfolio
  42. 7.7.5 Medipost Recent Developments
  43. 7.8 Magellan
  44. 7.8.1 Magellan Company Information
  45. 7.8.2 Magellan Business Overview
  46. 7.8.3 Magellan Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Magellan Stem Cell Therapy for Osteoarthritis Product Portfolio
  48. 7.8.5 Magellan Recent Developments
  49. 7.9 CellTex Therapeutics
  50. 7.9.1 CellTex Therapeutics Company Information
  51. 7.9.2 CellTex Therapeutics Business Overview
  52. 7.9.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product Portfolio
  54. 7.9.5 CellTex Therapeutics Recent Developments
  55. 7.10 Cells for Cells
  56. 7.10.1 Cells for Cells Company Information
  57. 7.10.2 Cells for Cells Business Overview
  58. 7.10.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cells for Cells Stem Cell Therapy for Osteoarthritis Product Portfolio
  60. 7.10.5 Cells for Cells Recent Developments
  61. 7.11 AbelZeta Pharma
  62. 7.11.1 AbelZeta Pharma Company Information
  63. 7.11.2 AbelZeta Pharma Business Overview
  64. 7.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product Portfolio
  66. 7.11.5 AbelZeta Pharma Recent Developments
8 North America
  1. 8.1 North America Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
  2. 8.2 North America Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2032)
  3. 8.2.1 North America Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026)
  4. 8.2.2 North America Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032)
  5. 8.3 North America Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032)
  6. 8.4 North America Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2032)
  7. 8.4.1 North America Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026)
  8. 8.4.2 North America Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032)
  9. 8.5 North America Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032)
  10. 8.6 North America Stem Cell Therapy for Osteoarthritis Revenue by Country
  11. 8.6.1 North America Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026)
  13. 8.6.3 North America Stem Cell Therapy for Osteoarthritis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
  2. 9.2 Europe Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032)
  5. 9.3 Europe Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032)
  9. 9.5 Europe Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Stem Cell Therapy for Osteoarthritis Revenue by Country
  11. 9.6.1 Europe Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Stem Cell Therapy for Osteoarthritis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
  2. 10.2 China Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2032)
  3. 10.2.1 China Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026)
  4. 10.2.2 China Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032)
  5. 10.3 China Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032)
  6. 10.4 China Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2032)
  7. 10.4.1 China Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026)
  8. 10.4.2 China Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032)
  9. 10.5 China Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
  2. 11.2 Asia Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032)
  5. 11.3 Asia Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032)
  9. 11.5 Asia Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Stem Cell Therapy for Osteoarthritis Revenue by Country
  11. 11.6.1 Asia Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Stem Cell Therapy for Osteoarthritis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Stem Cell Therapy for Osteoarthritis Revenue (2021-2032)
  2. 12.2 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Stem Cell Therapy for Osteoarthritis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Stem Cell Therapy for Osteoarthritis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country
  11. 12.6.1 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Stem Cell Therapy for Osteoarthritis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst